# Neuphoria Therapeutics Inc.: Form SCHEDULE 13D, filed Oct 23, 2025

- Company: [Neuphoria Therapeutics Inc.](/companies/neup.md) (CIK 1191070)
- Form: SCHEDULE 13D
- Filed: 2025-10-23
- Accepted by EDGAR: Oct 23, 2025, 23:52 ET
- Period: not reported
- Accession: 0000902664-25-004537
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1191070/000090266425004537/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1191070/000090266425004537/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1191070/000090266425004537/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 23, 2025.
Source: SEC EDGAR, the filing index for accession 0000902664-25-004537. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.